Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab.

Channa R, Sophie R, Khwaja AA, Do DV, Hafiz G, Nguyen QD, Campochiaro PA; READ-2 Study Group.

Eye (Lond). 2014 Mar;28(3):269-78. doi: 10.1038/eye.2013.245. Epub 2013 Nov 22.

PMID:
24263379
[PubMed - in process]
2.

Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.

Do DV, Nguyen QD, Khwaja AA, Channa R, Sepah YJ, Sophie R, Hafiz G, Campochiaro PA; READ-2 Study Group.

JAMA Ophthalmol. 2013 Feb;131(2):139-45.

PMID:
23544200
[PubMed - indexed for MEDLINE]
3.

Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion.

Tan MH, McAllister IL, Gillies ME, Verma N, Banerjee G, Smithies LA, Wong WL, Wong TY.

Am J Ophthalmol. 2014 Jan;157(1):237-247.e1. doi: 10.1016/j.ajo.2013.08.013. Epub 2013 Oct 7.

PMID:
24112635
[PubMed - indexed for MEDLINE]
4.

Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.

Ozturk BT, Kerimoglu H, Bozkurt B, Okudan S.

J Ocul Pharmacol Ther. 2011 Aug;27(4):373-7. doi: 10.1089/jop.2010.0195. Epub 2011 Jun 1.

PMID:
21631366
[PubMed - indexed for MEDLINE]
5.

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

Retina. 2006 Nov-Dec;26(9):999-1005.

PMID:
17151486
[PubMed - indexed for MEDLINE]
6.

Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.

Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG.

Ophthalmology. 2011 Oct;118(10):2041-9. doi: 10.1016/j.ophtha.2011.02.038. Epub 2011 Jun 29.

PMID:
21715011
[PubMed - indexed for MEDLINE]
7.

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS; RISE and RIDE Research Group.

Ophthalmology. 2012 Apr;119(4):789-801. doi: 10.1016/j.ophtha.2011.12.039. Epub 2012 Feb 11.

PMID:
22330964
[PubMed - indexed for MEDLINE]
8.

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ; RIDE and RISE Research Group.

Ophthalmology. 2013 Oct;120(10):2013-22. doi: 10.1016/j.ophtha.2013.02.034. Epub 2013 May 22.

PMID:
23706949
[PubMed - indexed for MEDLINE]
Free Article
9.

Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography.

Bhisitkul RB, Campochiaro PA, Shapiro H, Rubio RG.

Ophthalmology. 2013 May;120(5):1057-63. doi: 10.1016/j.ophtha.2012.11.011. Epub 2013 Feb 14.

PMID:
23415775
[PubMed - indexed for MEDLINE]
10.

Glucose regulation influences treatment outcome in ranibizumab treatment for diabetic macular edema.

Ozturk BT, Kerimoglu H, Adam M, Gunduz K, Okudan S.

J Diabetes Complications. 2011 Sep-Oct;25(5):298-302. doi: 10.1016/j.jdiacomp.2010.09.006. Epub 2010 Nov 13.

PMID:
21075650
[PubMed - indexed for MEDLINE]
11.

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG; BRAVO Investigators.

Ophthalmology. 2010 Jun;117(6):1102-1112.e1. doi: 10.1016/j.ophtha.2010.02.021. Epub 2010 Apr 15.

PMID:
20398941
[PubMed - indexed for MEDLINE]
12.

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.

Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, Mitchell P, Sharp D, Wolf-Schnurrbusch UE, Gekkieva M, Weichselberger A, Wolf S.

Diabetes Care. 2010 Nov;33(11):2399-405. doi: 10.2337/dc10-0493.

PMID:
20980427
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Selective retina therapy (SRT) for clinically significant diabetic macular edema.

Roider J, Liew SH, Klatt C, Elsner H, Poerksen E, Hillenkamp J, Brinkmann R, Birngruber R.

Graefes Arch Clin Exp Ophthalmol. 2010 Sep;248(9):1263-72. doi: 10.1007/s00417-010-1356-3.

PMID:
20393742
[PubMed - indexed for MEDLINE]
14.

Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study.

Lang GE, Berta A, Eldem BM, Simader C, Sharp D, Holz FG, Sutter F, Gerstner O, Mitchell P; RESTORE Extension Study Group.

Ophthalmology. 2013 Oct;120(10):2004-12. doi: 10.1016/j.ophtha.2013.02.019. Epub 2013 May 29.

PMID:
23725735
[PubMed - indexed for MEDLINE]
15.

Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.

Pieramici DJ, Rabena M, Castellarin AA, Nasir M, See R, Norton T, Sanchez A, Risard S, Avery RL.

Ophthalmology. 2008 Oct;115(10):e47-54. doi: 10.1016/j.ophtha.2008.06.021. Epub 2008 Aug 16.

PMID:
18708258
[PubMed - indexed for MEDLINE]
16.

Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema.

Carpineto P, Ciancaglini M, Di Antonio L, Gavalas C, Mastropasqua L.

Retina. 2007 Jan;27(1):21-9.

PMID:
17218911
[PubMed - indexed for MEDLINE]
17.

The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.

Soliman W, Sander B, Soliman KA, Yehya S, Rahamn MS, Larsen M.

Acta Ophthalmol. 2008 May;86(3):284-91. Epub 2007 Nov 13.

PMID:
18005220
[PubMed - indexed for MEDLINE]
18.

Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.

Rouvas A, Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I.

Retina. 2010 Jun;30(6):893-902. doi: 10.1097/IAE.0b013e3181cd4894.

PMID:
20531142
[PubMed - indexed for MEDLINE]
19.

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY; CRUISE Investigators.

Ophthalmology. 2010 Jun;117(6):1124-1133.e1. doi: 10.1016/j.ophtha.2010.02.022. Epub 2010 Apr 9.

PMID:
20381871
[PubMed - indexed for MEDLINE]
20.

[Evaluate the effectiveness of laser therapy in the treatment of diabetic maculopathy].

Mrugacz M, Krajewska M, Bryl A, Szuszkiewicz M.

Pol Merkur Lekarski. 2013 Jun;34(204):351-4. Polish.

PMID:
23882935
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk